Researching and developing novel therapeutics for individuals and families with ALS.
The Eleanor and Lou Gehrig ALS Center leads an integrated ALS research program at Columbia University that spans basic, translational, and clinical efforts across multiple schools, departments, institutes, and centers throughout our institution. Through a growing understanding of motor neuron disease mechanisms, our efforts focus on the development of novel therapeutics for individuals and families with ALS.
Patient-based research at the ALS Center includes brain imaging, genomic and observational studies, stem cell generation, and biofluid and tissue banking programs. These serve as the foundation of efforts to explore disease mechanisms, identify new therapeutic targets, and test novel candidate drugs and strategies which drive clinical research.